ALS-associated ANXA11 mutations also altered the phase transition properties of other RNA granule-associated proteins, slowing both FRAP kinetics of G3BP1 and the disassembly rate of G3BP1 granules following stress release (Figures S4F–S4I). The gene discussed is ANXA11; the disease is amyotrophic lateral sclerosis.